Redcliffe Labs has appointed Kshitiz Singh as its Chief Business Officer – Inorganic Growth, reinforcing the company's focus on strategic expansion and strengthening its diagnostics ecosystem across India.

In his new role, Singh will lead the company's inorganic growth initiatives, oversee strategic partnerships, and drive business integration efforts aimed at accelerating Redcliffe Labs' growth trajectory.

Singh brings more than 26 years of experience spanning diagnostics, healthcare, pharmaceuticals, FMCG, sales leadership, and business development. His extensive industry expertise is expected to play a key role in identifying and executing growth opportunities through acquisitions, collaborations, and strategic alliances.

Prior to joining Redcliffe Labs, Singh served as General Manager and Business Head at Agilus Diagnostics. During his career, he has held leadership positions at Metropolis Healthcare, Piramal Enterprises, Abbott India, Heinz India, Sanofi, AstraZeneca, and GlaxoSmithKline, where he contributed to business expansion and commercial excellence across multiple healthcare segments.

The appointment underscores Redcliffe Labs' commitment to expanding its presence across India while enhancing its capabilities through strategic growth initiatives and partnerships.